Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rollover Study of Mitapivat in Adult Pyruvate Kinase Deficiency (AG348-C-025)
jRCT2031230034Active, not recruiting
- Sponsor
- Agios Pharmaceuticals
- Start
- Jul 2023
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Open-label, single-arm trial of mitapivat in pyruvate kinase deficiency (PKD), sponsored by Agios Pharmaceuticals. Started Jul 2023; status: active, not recruiting.
02
Drugs
mitapivat
03
Conditions
pyruvate kinase deficiency (PKD)
Beyond the preview
Go deeper on jRCT2031230034.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031230034.